Open Access

LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa

  • Authors:
    • Bruna De Felice
    • Pasquale De Luca
    • Concetta Montanino
    • Marta Mallardo
    • Graziella Babino
    • Edi Mattera
    • Raffaele Sorbo
    • Giovanni Ragozzino
    • Giuseppe Argenziano
    • Aurora Daniele
    • Ersilia Nigro
  • View Affiliations

  • Published online on: May 2, 2024     https://doi.org/10.3892/mmr.2024.13236
  • Article Number: 112
  • Copyright: © De Felice et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Long noncoding RNAs (lncRNAs) have been demonstrated to be involved in biological processes, both physiological and pathological, including cancer, cardiovascular diseases, multiple sclerosis, autoimmune hepatitis and types I and II diabetes. LncRNAs are also known to have a critical role in the physiology of skin, and in the pathology of cutaneous diseases. LncRNAs are involved in a wide range of biological activities, including transcriptional post‑transcriptional processes, epigenetics, RNA splicing, gene activation and or silencing, modifications and/or editing; therefore, lncRNAs may be useful as potential targets for disease treatment. Hidradenitis suppurativa (HS), also termed acne inversa, is a major skin disease, being an inflammatory disorder that affects ~1% of global population in a chronic manner. Its pathogenesis, however, is only partly understood, although immune dysregulation is known to have an important role. To investigate the biological relevance of lncRNAs with HS, the most differentially expressed lncRNAs and mRNAs were first compared. Furthermore, the lncRNA‑microRNA regulatory network was also defined via reverse transcription‑quantitative PCR analysis, whereby a trio of lncRNA expression signatures, lncRNA‑TINCR, lncRNA‑RBM5‑ASI1 and lncRNA‑MRPL23‑AS1, were found to be significantly overexpressed in patients with HS compared with healthy controls. In conclusion, the three lncRNAs isolated in the present study may be useful for improving the prognostic prediction of HS, as well as contributing towards an improved understanding of the underlying pathogenic mechanisms, thereby potentially providing new therapeutic targets.
View Figures
View References

Related Articles

Journal Cover

July-2024
Volume 30 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
De Felice B, De Luca P, Montanino C, Mallardo M, Babino G, Mattera E, Sorbo R, Ragozzino G, Argenziano G, Daniele A, Daniele A, et al: LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa. Mol Med Rep 30: 112, 2024
APA
De Felice, B., De Luca, P., Montanino, C., Mallardo, M., Babino, G., Mattera, E. ... Nigro, E. (2024). LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa. Molecular Medicine Reports, 30, 112. https://doi.org/10.3892/mmr.2024.13236
MLA
De Felice, B., De Luca, P., Montanino, C., Mallardo, M., Babino, G., Mattera, E., Sorbo, R., Ragozzino, G., Argenziano, G., Daniele, A., Nigro, E."LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa". Molecular Medicine Reports 30.1 (2024): 112.
Chicago
De Felice, B., De Luca, P., Montanino, C., Mallardo, M., Babino, G., Mattera, E., Sorbo, R., Ragozzino, G., Argenziano, G., Daniele, A., Nigro, E."LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa". Molecular Medicine Reports 30, no. 1 (2024): 112. https://doi.org/10.3892/mmr.2024.13236